NCT02065453

Brief Summary

Over 600,000 hysterectomies are performed each year nationwide. Over 99% of these are accomplished laparoscopically in the investigators current surgical practice to allow women a quicker recovery than a traditional large incision. Disposable laparoscopic devices have been developed to assist in the completion of hysterectomies. These disposable energy sources are only used once, but offer an improved safety and energy profile in that they reliably control bleeding with little damage to surrounding tissue and potentially save time. Reusable energy instruments can be sterilized and reused for multiple cases. Operating room time is expensive. The investigators calculate that if 6.7 minutes of time can be saved using the disposable device, Ligasure (Covidien), versus the reusable Robi bipolar and Storz Laparoscopic Shears, the time savings could justify the cost of the device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 11, 2014

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 19, 2014

Completed
3.3 years until next milestone

Results Posted

Study results publicly available

June 14, 2017

Completed
Last Updated

June 14, 2017

Status Verified

May 1, 2017

Enrollment Period

2 years

First QC Date

February 11, 2014

Results QC Date

May 20, 2015

Last Update Submit

May 12, 2017

Conditions

Keywords

lap hysterectomyWomen in need of a lap hysterectomy for benign disease.

Outcome Measures

Primary Outcomes (1)

  • The Primary Endpoint of This Study is Time Difference Between Cauterizing One Side of the Uterine Attachments, From the Round Ligament to the Uterine Artery on One Side, to the Time Detaching the Same Tissues on the Other Side

    duration of surgery

    Primary outcome study data is collected with the first incision and completed with skin closure at the completion of the surgery.

Study Arms (2)

Disposable Device - Left & Reusable Devices - Right

OTHER

One side of the uterine attachments would be transected using the disposable device (Ligasure, Covidien).

Device: disposable device (Ligasure, Covidien)Device: Reusable device

Disposable Device - Right & Reusable Devices - Left

OTHER

One side of the uterine attachments would be transected using the reusable Robi bipolar and Storz laparoscopic

Device: disposable device (Ligasure, Covidien)Device: Reusable device

Interventions

One side of the uterine attachments would be transected using the disposable device (Ligasure, Covidien). . We will randomize the side for each energy source used on each side for every case. The number of "sides" performed by the attending surgeon will equal that of the less experienced resident surgeon.

Also known as: disposable device (Ligasure made by Covidien).
Disposable Device - Left & Reusable Devices - RightDisposable Device - Right & Reusable Devices - Left

One side of the uterine attachments would be transected using the reusable Robi bipolar and Storz laparoscopic

Also known as: Robi bipolar and Storz laparoscopic
Disposable Device - Left & Reusable Devices - RightDisposable Device - Right & Reusable Devices - Left

Eligibility Criteria

Age21 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 21 to 80 years of age
  • Scheduled for laparoscopic hysterectomy (prospectively)

You may not qualify if:

  • Under 21 years of age
  • Known or anticipated malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Louis University

St Louis, Missouri, 63117, United States

Location

Results Point of Contact

Title
M. Brigid Holloran-Schwartz, MD
Organization
Saint Louis University

Study Officials

  • Mary B Holloran-Schwartz, MD

    St. Louis University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 11, 2014

First Posted

February 19, 2014

Study Start

January 1, 2012

Primary Completion

January 1, 2014

Study Completion

January 1, 2014

Last Updated

June 14, 2017

Results First Posted

June 14, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will not share

No plan to share data

Locations